Welmedis
GmbH

Welmedis GmbH’s vision is a world in which people can make well-informed decisions about their health. Welmedis has therefore assembled a team of geneticists and scientists who use cutting-edge technologies to advance new scientific knowledge, develop new products and raise standards in health, medicine and well-being. The company’s research and development department has an established drug development pipeline that can be used for the design, synthesis, optimisation, validation and formulation of novel anti-cancer agents. Welmedis was founded in 2016 and is headquartered in Switzerland.